Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
210
Trial Sponsor
Clinical Trial Start Date
August 15, 2023
0Primary Completion Date
September 4, 2039
0Study Completion Date
September 4, 2039
0Clinical Trial Study Type
Observational0
Intervention Type
Diagnostic Test0
Other0
Intervention Name
Blood sample0
Urine sample0
Lifestyle questionnaire0
Observational Clinical Trial Type
Case-Control0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
Long-Term Follow-Up of Patients Who Have Received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg Therapy, TX200-TR101) in a Prior Clinical Study0
Last Updated
October 5, 2023
0Study summary
This long-term follow-up study is being conducted to collect long-term (up to 15 years post-infusion) safety and tolerability data from subjects enrolled in studies evaluating TX200-TR101.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
